Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketoprofen and Loxoprofen Platinum(IV) Complexes Displaying Antimetastatic Activities by Inducing DNA Damage, Inflammation Suppression, and Enhanced Immune Response
Zuojie Li, Qingpeng Wang, Linming Li, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 24, pp. 17920-17935
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Developing a Copper(II) Agent Based on His-146 and His-242 Residues of Human Serum Albumin Nanoparticles: Integration To Overcome Cisplatin Resistance and Inhibit the Metastasis of Nonsmall Cell Lung Cancer
Ming Jiang, Zhenlei Zhang, Wenjuan Li, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 9447-9458
Closed Access | Times Cited: 45
Beyond mere DNA damage: Recent progress in platinum(IV) anticancer complexes containing multi-functional axial ligands
Zhiqin Deng, Guangyu Zhu
Current Opinion in Chemical Biology (2023) Vol. 74, pp. 102303-102303
Closed Access | Times Cited: 31
Development of Clioquinol Platinum(IV) Conjugates as Autophagy-Targeted Antimetastatic Agents
Ming Zhang, Linming Li, Suying Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3393-3410
Closed Access | Times Cited: 26
Natural Products as Regulators against Matrix Metalloproteinases for the Treatment of Cancer
Md. Towhedul Islam, Nak Han Jang, Hyuck Jin Lee
Biomedicines (2024) Vol. 12, Iss. 4, pp. 794-794
Open Access | Times Cited: 15
Series of Desloratadine Platinum(IV) Hybrids Displaying Potent Antimetastatic Competence by Inhibiting Epithelial–Mesenchymal Transition and Arousing Immune Response
Ming Zhang, Yan Chen, Zhifang Liu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 2031-2048
Closed Access | Times Cited: 14
Iridium(III)-Based PD-L1 Agonist Regulates p62 and ATF3 for Enhanced Cancer Immunotherapy
Dongping Deng, Mengmeng Wang, Yan Su, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6810-6821
Closed Access | Times Cited: 9
Pt(IV) Prodrugs with Non-Steroidal Anti-inflammatory Drugs in the Axial Position
Daniil Spector, Kirill G. Pavlov, Roman Akasov, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 12, pp. 8227-8244
Closed Access | Times Cited: 36
NSAID–Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer
Zhongren Xu, Qiuyue Lu, Min Shan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 12, pp. 7813-7833
Closed Access | Times Cited: 22
Novel NF-κB Inhibitor-Conjugated Pt(IV) Prodrug to Enable Cancer Therapy through ROS/ER Stress and Mitochondrial Dysfunction and Overcome Multidrug Resistance
Meng Wang, Guimei Li, Guiyang Jiang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6218-6237
Closed Access | Times Cited: 8
Glycyrrhetinic Acid as a Hepatocyte Targeting Ligand-Functionalized Platinum(IV) Complexes for Hepatocellular Carcinoma Therapy and Overcoming Multidrug Resistance
Xiaochao Huang, Guimei Li, Huifang Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 8020-8042
Closed Access | Times Cited: 6
Development of a series of flurbiprofen and zaltoprofen platinum(iv) complexes with anti-metastasis competence targeting COX-2, PD-L1 and DNA
Zuojie Li, Linming Li, Wenhuan Zhao, et al.
Dalton Transactions (2022) Vol. 51, Iss. 33, pp. 12604-12619
Closed Access | Times Cited: 25
Metal Complexes as Promising Matrix Metalloproteinases Regulators
Yen Thi Nguyen, Namdoo Kim, Hyuck Jin Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1258-1258
Open Access | Times Cited: 13
A series of ligustrazine platinum(iv) complexes with potent anti-proliferative and anti-metastatic properties that exert chemotherapeutic and immunotherapeutic effects
Yan Chen, Linming Li, Zhifang Liu, et al.
Dalton Transactions (2023) Vol. 52, Iss. 37, pp. 13097-13109
Closed Access | Times Cited: 13
From aryl chlorides to phenols: Photouranium-catalyzed hydroxylation via water splitting
Mengjing Sun, Leiyang Bai, Chengliang Li, et al.
Chem Catalysis (2024) Vol. 4, Iss. 7, pp. 101027-101027
Closed Access | Times Cited: 5
Canadine Platinum(IV) Complexes Targeting Epithelial–Mesenchymal Transition as Antiproliferative and Antimetastatic Agents
Yan Chen, Ming Zhang, Yan‐Qin He, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 12868-12886
Closed Access | Times Cited: 5
Ursodeoxycholic Acid Platinum(IV) Conjugates as Antiproliferative and Antimetastatic Agents: Remodel the Tumor Microenvironment through Suppressing JAK2/STAT3 Signaling
Yan Chen, Ming Zhang, Zhifang Liu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 5
Multi-specific niflumic acid platinum(iv) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage
Linming Li, Ming Zhang, Dianlong Jia, et al.
Dalton Transactions (2022) Vol. 52, Iss. 1, pp. 147-158
Closed Access | Times Cited: 19
Discovery of PlatinumIV–Artesunate Multiaction Prodrugs as Potent Antitumor and Antimalarial Agents
Wei Liu, Chuyi Yu, Miaomiao Wang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 12, pp. 8066-8085
Closed Access | Times Cited: 12
Dual–target platinum(IV) complexes reverse cisplatin resistance in triple negative breast via inhibiting poly(ADP–ribose) polymerase (PARP–1) and enhancing DNA damage
Rui Li, Weiheng Zhao, Jin Chen, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106354-106354
Closed Access | Times Cited: 11
Hydroxychloroquine Platinum(IV) Conjugate Displaying Potent Antimetastatic Activities by Suppressing Autophagy to Improve the Tumor Microenvironment
Linming Li, Yan Chen, Ming Zhang, et al.
Dalton Transactions (2024) Vol. 53, Iss. 33, pp. 13890-13905
Closed Access | Times Cited: 4
Harnessing HDAC-targeted oleanolic acid derivatives for combined anti-cancer and hepatoprotective effects
Zhicheng Gu, Miao Deng, Luo Qiu-jiang, et al.
International Journal of Biological Macromolecules (2025), pp. 139761-139761
Closed Access
Novel Indoleamine-2,3-Dioxygenase-Targeted Pt(IV) Prodrugs Regulate the Tumor Immune Microenvironment to Achieve Chemoimmunotherapy In Vitro and In Vivo
Zhe Li, Xiaomeng Liu, Fei Tan, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Discovery of a Novel EF24 Analogue-Conjugated Pt(IV) Complex as Multi-Target Pt(IV) Prodrugs Aims to Enhance Anticancer Activity and Overcome Cisplatin Resistance
Meng Wang, Guimei Li, Nan Xu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Metallodrugs: From mere cytotoxic agents to immune modulators and checkpoint inhibitors
Muhammad Nafees, Muhammad Hanif, Piaoping Yang
Chinese Chemical Letters (2025), pp. 111013-111013
Closed Access
Repaglinide platinum(IV) conjugates: Enhancing p53 signaling for antitumor and antimetastatic efficacy
Suying Li, Zhifang Liu, Yan Chen, et al.
Journal of Inorganic Biochemistry (2025), pp. 112910-112910
Closed Access
Page 1 - Next Page

Scroll to top